myh1 Antibody

What is MYH1 and what cellular functions does it participate in?

MYH1 (MyHC-2x) encodes the IIX isoform of myosin heavy chain and plays a crucial role in muscle contraction. It belongs to the type 2 (fast) muscle fiber category, though research indicates it may influence slow muscle composition as well. Myosin functions as a motor protein that generates force through interaction with actin, participating in various cellular processes including cytokinesis, karyokinesis, cell migration, and most notably, muscle contraction. The molecular weight of MYH1 is approximately 223 kDa, making it one of the larger proteins in skeletal muscle tissue .

Interestingly, recent research suggests that MYH1 may have more complex roles in muscle fiber type determination than previously thought. Ectopic overexpression studies have demonstrated that MYH1 can increase the proportion of slow muscle fibers and enhance oxidative capacity, potentially through interaction with other muscle-specific genes .

What applications are MYH1 antibodies routinely validated for?

MYH1 antibodies have been validated for multiple applications with varying dilution requirements:

The optimal dilution is often sample-dependent, so researchers should conduct titration experiments with their specific samples to determine optimal antibody concentration . For immunohistochemistry applications, antigen retrieval methods significantly impact staining quality, with many protocols recommending TE buffer (pH 9.0) or citrate buffer (pH 6.0) .

How do I distinguish between different myosin heavy chain isoforms when using antibodies?

Distinguishing between myosin isoforms requires careful antibody selection and experimental design. Many commercial antibodies target specific domains or epitopes of MYH1 that may have varying degrees of homology with other myosin isoforms. For instance, some antibodies specifically target the motor domain of MYH1, while others target regions near the C-terminus .

For definitive isoform identification, researchers should consider:

• Using isoform-specific antibodies that have been validated for cross-reactivity

• Including appropriate controls from tissues known to express specific isoforms

• Employing complementary techniques such as mass spectrometry or RT-PCR

• Utilizing comparative immunoblotting with multiple antibodies targeting different epitopes

Interestingly, immunoblot studies using samples with varying type I fiber content have shown that while MYH7 antibodies (slow myosin) demonstrate major differences across fiber types, MYH1, MYH2, and MYH4 antibodies show relatively similar signal intensities across different fiber types , suggesting that quantitative analysis may require additional controls.

What are the optimal sample preparation methods for MYH1 detection in muscle tissue?

Optimal sample preparation for MYH1 detection varies by technique but generally requires preservation of protein structure while ensuring accessibility of the target epitope:

For Western Blotting:

• Fresh or flash-frozen muscle tissue is preferable

• Homogenization in RIPA buffer supplemented with protease inhibitors

• Sample heating at 95°C for 5 minutes in Laemmli buffer with β-mercaptoethanol

• Loading 20-30 μg of total protein per lane for optimal detection

For Immunohistochemistry:

• Either 4% paraformaldehyde fixation or standard formalin fixation

• Paraffin embedding with careful processing to avoid protein degradation

• 5-7 μm sections for optimal antibody penetration

• Critical heat-mediated antigen retrieval with either:

  • Tris-EDTA buffer (pH 9.0) for 20 minutes, or

  • Sodium citrate buffer (pH 6.0 + 0.05% Tween-20)

For Flow Cytometry:

• Gentle dissociation of muscle tissue to single cells

• 4% paraformaldehyde fixation

• Permeabilization with 0.2% Triton X-100

• Blocking with 5% normal serum

• Staining with approximately 0.40 μg antibody per 10^6 cells

The quality of tissue preservation significantly impacts antibody performance, with freshly collected samples generally yielding superior results compared to archived specimens.

How should I select between polyclonal and monoclonal MYH1 antibodies for my research?

The choice between polyclonal and monoclonal antibodies should be guided by your specific research application:

Polyclonal MYH1 Antibodies:

• Recognize multiple epitopes on the MYH1 protein

• Generally provide higher sensitivity for applications like Western blot

• May have higher background and potential cross-reactivity

• Useful when protein conformation might be altered (denatured samples)

• Examples include rabbit polyclonal antibodies (22282-1-AP, A46719) that target specific domains of MYH1

Monoclonal MYH1 Antibodies:

• Recognize a single epitope with high specificity

• Provide consistent lot-to-lot reproducibility

• Typically show lower background in immunohistochemistry

• May have lower sensitivity than polyclonal antibodies

• Examples include mouse monoclonal antibody [A4.1025] that targets MYH1/2

For advanced co-localization studies or when absolute specificity is required, monoclonal antibodies are often preferred. For detection of low-abundance targets or when sensitivity is paramount, polyclonal antibodies may yield better results. When possible, validating findings with both types provides stronger evidence .

What controls should be included when using MYH1 antibodies?

Rigorous control inclusion is essential for reliable MYH1 antibody experiments:

Primary Controls:

• Positive tissue control - Human or mouse skeletal muscle tissue (known to express MYH1)

• Negative tissue control - Tissues not expressing MYH1 (e.g., certain non-muscle tissues)

• Secondary antibody-only control - Omit primary antibody to assess non-specific binding

• Isotype control - Use matched isotype (e.g., Rabbit IgG) at equivalent concentration

• Peptide competition assay - Pre-incubation with immunizing peptide should abolish signal

Application-Specific Controls:

• For Western blot: Include C2C12 myoblasts (low expression) and differentiated C2C12 cells (higher expression)

• For IHC: Include cardiac muscle tissue with known myosin expression patterns

• For functional studies: Include samples with varying type I fiber content (12-76%) to calibrate relative expression levels

When analyzing fiber type composition, ATPase staining at different pH values (4.3 and 10.4) can serve as complementary controls to verify antibody-based fiber typing results .

Why might I observe non-specific binding with my MYH1 antibody?

Non-specific binding is a common challenge with MYH1 antibodies that can be addressed through systematic troubleshooting:

Common Causes and Solutions:

• Insufficient blocking:

  • Increase blocking time (2 hours to overnight)

  • Try alternative blocking agents (5% BSA, normal serum, commercial blockers)

  • Add 0.1-0.3% Triton X-100 to reduce hydrophobic interactions

• Excessive antibody concentration:

  • Perform titration experiments (1:500 to 1:2000 for WB, 1:20 to 1:200 for IHC)

  • Consider using antigen-purified antibodies when available

• Cross-reactivity with other myosin isoforms:

  • Select antibodies targeting unique epitopes of MYH1

  • Validate specificity using tissues with known myosin expression profiles

  • Consider pre-absorption against related proteins

• Sample processing issues:

  • Optimize fixation duration (overfixation can increase non-specific binding)

  • Ensure thorough washing steps (minimum 3×5 minutes)

  • Adjust antigen retrieval methods (compare citrate buffer pH 6.0 vs. TE buffer pH 9.0)

Antibodies like 22282-1-AP have undergone antigen affinity purification to reduce non-specific binding, but optimization for specific experimental conditions is still necessary .

What factors might affect antibody performance when studying MYH1 in different muscle fiber types?

Several factors can influence MYH1 antibody performance across different fiber types:

• Fiber type-specific protein modifications:

  • Post-translational modifications may mask epitopes in certain fiber types

  • Altered protein conformations can affect antibody accessibility

  • Protein-protein interactions within the sarcomere structure

• Technical considerations:

  • Fixation differentially affects fiber types (fast vs. slow fibers)

  • Antigen retrieval requirements vary between fiber types

  • Section thickness impacts antibody penetration in densely packed fibers

• Biological variability:

  • Expression levels of MYH1 vary across fiber types and physiological states

  • Co-expression of multiple myosin isoforms in hybrid fibers

  • Development or disease-associated transitions between fiber types

Interestingly, research has shown that while some myosin antibodies (like MYH7-specific antibodies) show dramatic differences in staining intensity across fiber types, MYH1 antibodies often show more similar intensities across fiber types, suggesting complex expression patterns . This highlights the importance of complementary techniques like ATPase staining (pH 4.3 and 10.4) and SDH staining to confirm fiber type identification in research studies .

How can MYH1 antibodies be used to study muscle fiber type transitions?

MYH1 antibodies serve as valuable tools for investigating muscle fiber type transitions in various physiological and pathological contexts:

Methodological Approaches:

• Longitudinal analysis:

  • Sequential muscle biopsies during interventions (exercise, immobilization)

  • Quantitative immunohistochemistry with fiber type-specific markers

  • Co-localization of MYH1 with metabolic enzymes or other myosin isoforms

• Transgenic modeling:

  • Analysis of MYH1 expression in genetically modified models

  • Comparison of ectopic MYH1 overexpression effects on fiber type composition

  • Co-immunoprecipitation to identify protein interaction partners

• Multi-parameter fiber typing:

  • Combined analysis of MYH1 with other fiber type markers

  • Integration with functional measurements (contractile properties)

  • Correlation with mitochondrial content (SDH staining)

Research has demonstrated that ectopic overexpression of MYH1 can increase the proportion of slow muscle fibers, with ATPase staining showing significant differences between wild-type and transgenic mice. At pH 4.3, transgenic mice showed 45% type I fibers (slow muscle) compared to 24.8% in wild-type mice. At pH 10.4, type I fibers increased from 36.6% in wild-type to 46.1% in transgenic mice . These findings suggest that MYH1 may play a previously unrecognized role in fiber type determination.

What techniques combine MYH1 antibodies with functional muscle fiber analysis?

Integration of MYH1 antibody-based detection with functional analyses provides comprehensive insights into muscle physiology:

Combined Methodological Approaches:

• Single fiber isolation and analysis:

  • Laser capture microdissection of individual fibers

  • Immunoblotting for MYH1 in isolated fibers

  • Correlation with contractile properties or calcium handling

• In situ functional imaging:

  • Calcium imaging combined with post-hoc immunostaining

  • Force measurements of identified fiber bundles

  • Metabolic imaging with subsequent MYH1 detection

• Multi-omics integration:

  • Correlation of MYH1 protein levels with transcriptomics

  • Proteomics of MYH1-expressing fibers

  • Metabolomic profiling linked to fiber type

Advanced techniques have enabled quantification of myosin content in individual muscle fibers isolated by laser capture microdissection. These approaches have revealed that while MYH7 (slow myosin) content varies dramatically across fiber types, MYH1, MYH2, and MYH4 show more similar signal intensities across different fiber types. This suggests complex regulatory mechanisms beyond simple protein abundance .

For functional correlations, researchers can combine succinate dehydrogenase (SDH) staining with MYH1 immunodetection to assess both mitochondrial oxidative capacity and myosin isoform expression in the same fibers .

How should I quantify MYH1 expression in heterogeneous muscle samples?

Quantifying MYH1 expression in mixed fiber type samples requires careful methodological approaches:

Recommended Quantification Strategies:

• Fiber type-specific analysis:

  • Classify individual fibers based on myosin isoform expression

  • Measure MYH1 intensity within each classified fiber

  • Calculate both percentage of MYH1-positive fibers and signal intensity

• Western blot quantification:

  • Normalize to appropriate loading controls (total protein stain preferred)

  • Compare to reference samples with known fiber type composition

  • Account for sample variability with biological replicates

• Advanced digital pathology:

  • Whole-slide scanning with automated fiber detection

  • Machine learning algorithms for fiber classification

  • Multi-parameter correlation (size, shape, intensity)

The relationship between type I fiber content and MYH1 expression can be complex. Studies examining muscle samples with type I fiber content ranging from 12% to 76% have shown that while MYH7 and fast/slow myosin MAbs show clear correlations with fiber type, MYH1 bands show relatively similar intensities across subjects with different fiber type compositions . This suggests that absolute quantification should be interpreted with caution.

What are the implications of altered MYH1 expression in physiological and pathological conditions?

Altered MYH1 expression has significant implications for muscle function in various contexts:

Physiological Implications:

• Exercise adaptation:

  • Endurance training may alter MYH1 expression patterns

  • Resistance training induces fiber type-specific adaptations

  • Recovery processes involve coordinated myosin isoform transitions

• Aging and development:

  • Age-related shifts in fiber type composition

  • Developmental regulation of myosin isoform expression

  • Regenerative capacity linked to myosin expression patterns

Pathological Implications:

• Neuromuscular disorders:

  • Altered myosin expression in muscular dystrophies

  • Denervation-induced fiber type transitions

  • Potential therapeutic targets for maintaining muscle function

• Metabolic disorders:

  • Changes in MYH1 expression with insulin resistance

  • Relationship between fiber type and metabolic health

  • Therapeutic implications of fiber type modulation

Research has demonstrated that overexpression of MYH1 can increase the proportion of slow muscle fibers and enhance oxidative capacity. Transgenic mice overexpressing MYH1 showed upregulation of slow muscle-associated genes including myoglobin and slow sarcomeric genes (Tnnt1, Tnnti1, Tnnc1), while fast sarcomeric genes remained largely unchanged. This was accompanied by improved oxidative endurance, suggesting functional relevance . These findings indicate that MYH1 may represent a potential therapeutic target for conditions requiring enhanced oxidative metabolism or fiber type modulation.